Assertio Therapeutics
Presence
Assertio Therapeutics is one of the...
Assertio Therapeutics is a company listed under the stock ticker DEPO (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Assertio Therapeutics
- Heather Mason, Interim Chief Executive Officer and Director
- James Tyree, Independent Director
- Peter Staple, Chairman of the Board
Popular executive movements at Assertio Therapeutics
- Sigurd Kirk has joined the company as Director (posted on April 5 2024).
- Daniel Peisert, Chief Executive Officer and Director, has left the company (posted on January 4 2024).
- Heather Mason, who was Director, is promoted to Interim Chief Executive Officer and Director (posted on January 4 2024).
Click here to view some more movements at Assertio Therapeutics
Create your alert
to follow the executive moves at Assertio Therapeutics.
Pharmaceuticals
Assertio Therapeutics has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Assertio Therapeutics
- Sig Kirk Joins Assertio Board of Directors
- Assertio to Present at LD Micro Invitational Conference in New York City
- Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
- Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
- Assertio Holdings, Inc. - Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Assertio Holdings, Inc. - Assertio Holdings, Inc. Announces Leadership Transition
- Assertio Holdings, Inc. - Assertio Reports Third Quarter 2023 Financial Results
- Assertio Holdings, Inc. - Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors
- Assertio Holdings, Inc. - Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- View more press releases Close
Social media about Assertio Therapeutics
- Assertio Therapeutics on Wikipedia, Google News & Yahoo Finance
- Assertio Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Sigurd Kirk 
Call Assertio Therapeutics at +1 510...
